Company intelligence / Profile preview

VectorVision

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

VectorVision is the worldwide leader in standardized vision testing devices for contrast sensitivity, glare sensitivity, and ETDRS acuity, validated by over 100 scientific publications and used in clinics and clinical trials across more than 60 countries.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Participated in clinical studies sponsored by AMOAlconAcuFocusPharmaciaOtsukaNovartis and others. Not formal partnerships but involvement in clinical trials.

Beyond the preview

Go deeper on VectorVision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VectorVision.

Explore the full profile